Bloomberg the Company & Its ProductsBloomberg Anywhere Remote LoginBloomberg Anywhere LoginBloomberg Terminal Demo Request

  • Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

    For Customers

  • Bloomberg Anywhere Remote Login
  • Software Updates
  • Manage Products and Account Information

    • Support

    Americas+1 212 318 2000

    EMEA+44 20 7330 7500

    Asia Pacific+65 6212 1000

  • Company

    • Bloomberg London
    • About
    • Careers
    • Diversity and Inclusion
    • Philanthropy and Engagement
    • Sustainability
    • Tech

    Communications

    • Press Announcements
    • Press Contacts

    Follow

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

  • Products

    • Bloomberg Terminal
    • Execution and Order Management
    • Data and Content
    • Financial Data Management
    • Integration and Distribution
    • Bloomberg Tradebook

    Industry Products

    • Bloomberg Law
    • Bloomberg Tax
    • Bloomberg Government
    • Bloomberg Environment
    • Bloomberg New Energy Finance

  • Media

    • Bloomberg Markets
    • Bloomberg Technology
    • Bloomberg Pursuits
    • Bloomberg Politics
    • Bloomberg Opinion
    • Bloomberg Businessweek
    • Bloomberg Live Conferences
    • Bloomberg Apps
    • Bloomberg Radio
    • Bloomberg Television
    • News Bureaus

    Media Services

    • Bloomberg Media Distribution
    • Advertising

  • Company

    • Bloomberg London
    • About
    • Careers
    • Diversity and Inclusion
    • Philanthropy and Engagement
    • Sustainability
    • Tech

    Communications

    • Press Announcements
    • Press Contacts

    Follow

    • Facebook
    • Twitter
    • LinkedIn
    • Instagram

  • Products

    • Bloomberg Terminal
    • Execution and
      Order Management
    • Data and Content
    • Financial Data
      Management
    • Integration and
      Distribution
    • Bloomberg
      Tradebook

    Industry Products

    • Bloomberg Law
    • Bloomberg Tax
    • Bloomberg Government
    • Bloomberg Environment
    • Bloomberg New Energy Finance

  • Media

    • Bloomberg Markets
    • Bloomberg
      Technology
    • Bloomberg Pursuits
    • Bloomberg Politics
    • Bloomberg Opinion
    • Bloomberg
      Businessweek
    • Bloomberg Live Conferences
    • Bloomberg Apps
    • Bloomberg Radio
    • Bloomberg Television
    • News Bureaus

    Media Services

    • Bloomberg Media Distribution
    • Advertising

  • Bloomberg

    Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

    For Customers

  • Bloomberg Anywhere Remote Login
  • Software Updates
  • Manage Contracts and Orders

    • Support

    Americas+1 212 318 2000

    EMEA+44 20 7330 7500

    Asia Pacific+65 6212 1000

MENU

    • About The Company
    • Bloomberg London
  • Homepage
  • Markets
    • Stocks
    • Currencies
    • Fixed Income
    • ETFs
    • Commodities
    • Rates + Bonds
    • Economics
    • Magazine
    • Benchmark
    • Watchlist
    • Economic Calendar
  • Tech
    • U.S.
    • Global
    • Startups
    • Bloomberg Technology TV
    • Gadgets With Gurman
    • Digital Defense
    • Studio 1.0
    • Focus On: Infrastructure
  • Pursuits
    • Cars & Bikes
    • Style & Grooming
    • Spend
    • Watches & Gadgets
    • Food & Drinks
    • Travel
    • Real Estate
    • Art & Design
    • Brilliant Ideas
  • Politics
    • Global Risk Briefing
    • All Signs Point to Big Democratic Wins in 2018
    • Trump Takes Credit for Killing Hundreds of Regulations That Were Already Dead
    • How China’s Top Leaders Came Into Power
    • How the Populist Right Is Redrawing the Map of Europe
  • Opinion
    • View
    • Gadfly
  • Businessweek
    • Latest Issue
    • Debrief Podcast
    • Subscribe
  • More
    • Crypto
    • Hyperdrive
    • Climate Changed
    • Focus On: Women
    • Graphics
    • Billionaires
    • Personal Finance
    • Inspire GO
    • Sponsored Content
    • Send Tips
  • Sign In
Sign In Subscribe to Businessweek
DJIA
24,462.94
S&P 500
2,670.14
NASDAQ
7,146.13
FTSE 100
7,368.17
NIKKEI 225 Future
22,050.00
  • Markets
  • Stocks
  • Currencies
  • Fixed Income
  • Commodities
  • Rates & Bonds
  • Sectors
  • Watchlist
Before it's here, it's on the Bloomberg Terminal.
Learn More
AZRX:USNASDAQ CM

AzurRx BioPharma Inc

3.44USD
-0.08-2.27%
Market Closed
As of 04/20/2018
Open
3.69
Prev Close
3.52
Volume
11,714
Market Cap
43.249M
Day Range
3.44-3.69
52 Week Range
2.31-5.25
1D1M1Y5Y
View Full Chart
Market Closed
As of 04/20/2018
1D1M1Y5Y
View Full Chart

Press Releases

AzurRx BioPharma Announces Positive Preclinical Data with AZX1103
April 18, 2018
Investors & Innovators to Come Together at BioNJ's BioPartnering Conference with J.P. Morgan
April 13, 2018
AzurRx BioPharma to Present at the 30th Annual ROTH Conference (March 12th)
February 28, 2018
AzurRx BioPharma Announces Enrollment of Three New Patients for its Phase IIa Study of MS1819-SD
February 12, 2018
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market: Rising Prevalence of Diabetes to Drive
February 9, 2018
AzurRx BioPharma to Present at the 2018 BIO CEO & Investor Conference (February 12th)
February 8, 2018
AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for E
January 18, 2018
AzurRx BioPharma Receives $2 Million in Proceeds from Exercise of Warrants
January 16, 2018
AzurRx BioPharma Announces Publication of U.S. Patent Application for AZX1101
December 20, 2017
AzurRx BioPharma to Present at the Biotech Showcase 2018 Conference (January 8th)
December 4, 2017
View More
Before it's here, it's on the Bloomberg Terminal.
Learn More

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding12.57M
Price to Book Ratio--
Price to Sales Ratio--
1 Year Return-14.00%
30 Day Avg Volume27,383
EPS-1.05
Bloomberg (BEst) EPS Curr Yr-0.6900
Dividend--
Last Dividend Reported--

Compare
1-Day Performance

-3%0
-3%0
Equity
AZRX:US
-2.27%
Sector
Health Care
-0.55%
Industry
Biotech & Pharma
-0.53%
Sponsored By

About AzurRx BioPharma Inc

AzurRx BioPharma, Inc. operates as a development stage biopharmaceutical company. The Company focuses on the research and development of recombinant proteins for the treatment of patients with gastrointestinal disorders and microbiome related conditions.
Address
Downstate Biotechnology Incuba 760 Parkside Avenue, Suite 217 Brooklyn, NY 11226 United States
Phone
1-646-699-7855
Website
www.azurrx.com

Executives

Name/Title
Johan M Spoor "Thijs"
President/CEO
Maged S Shenouda
Exec VP:Corporate Dev/CFO
Daniel Dupret
Chief Scientific Ofcr

Board Members

Name/Company
Edward J Borkowski "Ed"
Charles J Casamento "Chuck"
Maged S Shenouda
AzurRx BioPharma Inc
View More
View More

Income Statement

Quarterly
Annual
Q4 2017 (Millions USD)
  • Revenue
    0.0
  • Net Income
    -2.5
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
;
Q3 2017 (Millions USD)
  • Total Assets
    6.8
  • Total Liabilities
    4.0
  • Debt to Assets
    4.92%

Cash Flow

Quarterly
Annual
Q4 2017 (Millions USD)
  • Operating
    -2.5
  • Investing
    -0.0
  • Financing
    0.1
Terms of Service Trademarks Privacy Policy ©2018 Bloomberg L.P. All Rights Reserved
Careers Made in NYC Advertise Ad Choices Website Feedback Help